Caris Life Sciences Publishes Supporting Evidence For AI-Based Cancer Diagnosis

Caris Life Sciences has published a study in JAMA Network Open that presents evidence for an AI-based method to differentiate lung squamous cell carcinoma from metastases of other origins. This development could enhance cancer diagnosis accuracy. The company's stock ticker is CAI.